Effects of smoking and treatment status on periodontal bacteria: Evidence that smoking influences control of periodontal bacteria at the mucosal surface of the gingival crevice

Journal of Periodontology

Volumn 72, Issue 9, 2001, Pages 1210-1220

  Eggert, F Michael ^a   McLeod, M Herbert ^a   Flowerdew, Gordon ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Biological markers; Immunoassay; Oral hygiene; Periodontitis microbiology; Smoking adverse effects

Indexed keywords

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; AGE; ARTICLE; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; MALE; MICROBIOLOGY; MIDDLE AGED; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVENTIVE DENTISTRY; PREVOTELLA INTERMEDIA; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING; STATISTICAL MODEL;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; AGE FACTORS; DENTAL SCALING; FEMALE; HUMANS; IMMUNOBLOTTING; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; REGRESSION ANALYSIS; SEX FACTORS; SMOKING;

EID: 0035459586     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.72.9.1210     Document Type: Article

References (93)

1. Zambon JJ, Grossi SG, Machtei EE, Ho AW, Dunford R, Genco RJ. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol 1996;67:1050-1054.
2. Grossi SG, Zambon J, Machtei EE, et al. Effects of smoking and smoking cessation on healing after mechanical periodontal therapy. J Am Dent Assoc 1997;128:599-607.
3. Machtei EE, Dunford R, Hausmann E, et al. Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol 1997;24:102-109.
4. Preber H, Bergstrom J, Linder LE. Occurrence of periopathogens in smoker and non-smoker patients. J Clin Periodontol 1992;19:667-671.
5. Preber H, Linder L, Bergstrom J. Periodontal healing and periopathogenic microflora in smokers and non-smokers. J Clin Periodontol 1995;22:946-952.
6. Stoltenberg JL, Osborn JB, Pihlstrom BL, et al. Association between cigarette smoking, bacterial pathogens, and periodontal status. J Periodontol 1993;64:1225-1230.
7. Haffajee AD, Cugini MA, Dibart S, Smith C, Kent RL Jr., Socransky SS. The effect of SRP on the clinical and microbiological parameters of periodontal diseases. J Clin Periodontol 1997;24:324-334.
8. Renvert S, Dahlen G, Wikström M. The clinical and microbiological effects of non-surgical periodontal therapy in smokers and non-smokers. J Clin Periodontol 1998;25:153-157.
9. Lie MA, van der Weijden GA, Timmerman MF, Loos BG, van Steenbergen TJ, van der Velden U. Oral microbiota in smokers and non-smokers in natural and experimentally-induced gingivitis. J Clin Periodontol 1998;25:677-686.
10. Snyder B, Ryerson CC, Corona H, et al. Analytical performance of an immunologic-based periodontal bacterial test for simultaneous detection and differentiation of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia. J Periodontol 1996;67:497-505.
11. Eggert F-M, Flowerdew G, McLeod MH, McIntyre EW, Wasylyk J, Koschzeck L. Diagnostic utility of specific microbiological markers for periodontal diseases. J Periodontol 1998;69:1373-1381.
12. Eggert F-M, McLeod MH, Flowerdew G, McIntyre EW, Wasylyk J, Koschzeck L. Periodontitis-associated marker bacteria in an urban North American population: Application of a commercial immunoassay. J Periodontol 1998;69:1382-1391.
13. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996;67(Suppl.):1041-1049.
14. Tonetti MS. Cigarette smoking and periodontal diseases: Etiology and management of disease. Ann Periodontol 1998;3:88-101.
15. American Academy of Periodontology. Tobacco use and the periodontal patient (position paper). J Periodontol 1999;70:1419-1427.
16. Preber H, Bergstrom J. Cigarette smoking in patients referred for periodontal treatment. Scand J Dent Res 1986;94:102-108.
17. Bergstrom J. Cigarette smoking as a risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989;17:245-247.
18. Müller HP, Eger T, Lobinsky D, Hoffmann S, Zoller L. A longitudinal study of Actinobacillus actinomycetemcomitans in army recruits. J Periodont Res 1997;32:69-78.
19. McGuire MK, Nunn ME. Prognosis versus actual outcome. IV. The effectiveness of clinical parameters and IL-1 genotype in accurately predicting prognoses and tooth survival. J Periodontol 1999;70:44-56.
20. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
21. Grossi SG, Genco RJ, Machtei EE, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995;66:23-29.
22. Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL. Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol 1993;64:16-23.
23. Holm G. Smoking as an additional risk for tooth loss. J Periodontol 1994;65:996-1001.
24. Linden GJ, Mullally BH. Cigarette smoking and periodontal destruction in young adults. J Periodontol 1994;65:718-723.
25. Eggert F-M, McLeod MH, Flowerdew G. Performance of a commercial immunoassay for detection and differentiation of periodontal marker bacteria: Analysis of immunochemical performance with clinical samples. J Periodontol 2001;72:1201-1209.
26. Casadevall A, Pirofski L-A. Host-pathogen interactions: Redefining the basic concepts of virulence and pathogenicity. Infect Immun 1999;67:3703-3713.
27. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal conditions. Acta Odontol Scand 1964;22:121-135.
28. Bode L, Beutin L, Kohler H. Nitrocellulose-enzyme-linked immunosorbent assay (NC-ELISA)-a sensitive technique for the rapid visual detection of both viral antigens and antibodies. J Virol Methods 1984;8:111-121.
29. Kumar S, Band AH, Samantaray JC, Dang N, Talwar GP. A dot enzyme-linked immunosorbent assay for detection of antibodies against Entamoeba histolytica. J Immunol Methods 1985;83:125-133.
30. Berger PH, Thornbury DW, Pirone TP. Detection of picogram quantities of potyviruses using a dot blot immunobinding assay. J Virol Methods 1985;12:31-39.
31. Van Vooren JP, Turneer M, Yernault JC, et al. A multidot immunobinding assay for the serodiagnosis of tuberculosis. Comparison with an enzyme-linked immunosorbent assay. J Immunol Methods 1988;113:45-49.
32. Nuzzolo CA, Bernardi A, Verdini AS, Pessi A. A rapid inhibition micro ELISA for detecting antibodies to Plasmodium falciparum sporozoites in human blood. J Immunoassay 1990;11:389-412.
33. Van Kerckhoven I, Vercauteren G, Piot P, van der Groen G. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull WHO 1991;69:753-760.
34. Agresti A. Analysis of Ordinal Categorical Data. New York:J. Wiley; 1984:104-137.
35. Bland M. An Introduction to Medical Statistics, 2nd ed. Oxford: Oxford Medical Publications; 1995:306-316.
36. Chalmers I. Assembling comparison groups to assess the effects of health care. J Royal Soc Med 1997;90: 379-386.
37. Joffres MR, Titanich KL, Hessel PA. The Alberta heart health survey: Methods and results. Can J Cardiol 1993;9:300-308.
38. Slots J, Emrich LJ, Genco RJ, Rosling BG. Relationship between some subgingival bacteria and periodontal pocket depth and gain or loss of periodontal attachment after treatment of adult periodontitis. J Clin Periodontol 1985;12:540-552.
39. Albandar JM, Olsen I, Gjermo P. Associations between six DNA probe-detected periodontal bacteria and alveolar bone loss and other clinical signs of periodontitis. Acta Odontol Scand 1990;48:415-423.
40. Hanley S, Aduse-Opoku J, Curtis MA. A 55-kilodalton immunodominant antigen of Porphyromonas gingivalis W50 has arisen via horizontal gene transfer. Infect Immun 1999;67:1157-1171.
41. Loesche WJ, Gusberti, F, Mettraux G, Higgins T, Syed S. Relationship between oxygen tension and subgingival bacterial flora in untreated human periodontal pockets. Infect Immun 1983;42:659-667.
42. Hanioka T, Tanaka M, Takaya K, Matsumori Y, Shizukuishi S. Pocket oxygen tension in smokers and non-smokers with periodontal disease. J Periodontol 2000;71:550-554.
43. Bergstrom J. Oral hygiene compliance and gingivitis expression in cigarette smokers. Scand J Dent Res 1990;98:497-503.
44. Pucher JJ, Shibley O, Dentino AR, Ciancio SG. Results of limited initial periodontal therapy in smokers and non-smokers. J Periodontol 1997;68:851-856.
45. Axelsson P, Paulander J, Lindhe J. Relationship between smoking and dental status in 35-, 50-, 65-, and 75-year-old individuals. J Clin Periodontol 1998;25:297-305.
46. Monteiro da Silva AM, Newman HN, Oakley DA, O'Leary R. Psychosocial factors, dental plaque levels and smoking in periodontitis patients. J Clin Periodontol 1998;25:517-523.
47. Shiloah J, Patters MR, Waring MB. The prevalence of pathogenic periodontal microflora in healthy young adult smokers. J Periodontol 2000;71:562-567.
48. Bergstrom J, Persson L, Preber H. Influence of cigarette smoking on vascular reaction during experimental gingivitis. Scand J Dent Res 1988;96:34-39.
49. Danielsen B, Manji F, Nagelkerke N, Fejerskov O, Baelum V. Effect of cigarette smoking on the transition dynamics in experimental gingivitis. J Clin Periodontol 1990;17:159-164.
50. Müller H-P, Schaller N, Eger T, Heinecke A. Thickness of masticatory mucosa. J Clin Periodontol 2000;27:431-436.
51. Eggert F-M, McLeod MH, Flowerdew G. Effects of smoking and treatment status on periodontal marker bacteria (abstract). J Dent Res 1999;78:542.
52. Gmür R, Marinello CP, Guggenheim B. Periodontitis associated bacteria in supragingival plaque of dental hygienists: Stability of carrier state and clinical development. Euro J Oral Sci 1999;107:225-228.
53. Alaluusua S, Asikainen S. Detection and distribution of Actinobacillus actinomycetemcomitans in the primary dentition. J Periodontol 1988;59:504-507.
54. Milnes AR, Bowden GH, Gates D, Tate R. Normal microbiota on the teeth of preschool children. Microb Ecol Health Dis 1993;6:213-227.
55. Gmür R, Guggenheim B. Interdental supragingival plaque - a natural habitat of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, Campylobacter rectus, and Prevotella nigrescens. J Dent Res 1994;73: 1421-1428.
56. McNabb H, Mombelli A, Lang NP. Supragingival cleaning 3 times a week. The microbiological effects in moderately deep pockets. J Clin Periodontol 1992;19:348-356.
57. Kornman KS, Newman MG, Moore DJ, Singer RE. The influence of supragingival plaque control on clinical and microbial outcomes following the use of antibiotics for the treatment of periodontitis. J Periodontol 1994;65:848-854.
58. al-Yahfoufi Z, Mombelli A, Wicki A, Lang NP. The effect of plaque control in subjects with shallow pockets and high prevalence of periodontal pathogens. J Clin Periodontol 1995;22:78-84.
59. Hellstrom MK, Ramberg P, Krok L, Lindhe J. The effect of supragingival plaque control on the subgingival microflora in human periodontitis. J Clin Periodontol 1996;23:934-940.
60. Ertel A, Eng R, Smith SM. The differential effect of cigarette smoke on the growth of bacteria found in humans. Chest 1991;100:628-630.
61. Kamma JJ, Nakou M, Baehni PC. Clinical and microbiological characteristics of smokers with early onset periodontitis. J Periodont Res 1999;34:25-33.
62. Chiba M, Masironi R. Toxic and trace elements in tobacco and tobacco smoke. Bull WHO 1992;70:269-275.
63. Economides D, Braithwaite J. Smoking, pregnancy and the fetus. J Royal Soc Health 1994;114:198-201.
64. Coultas DB, Stidley CA, Samet JM. Cigarette yields of tar and nicotine and markers of exposure to tobacco smoke. Am Rev Respir Dis 1993;148:435-440.
65. Kenney EB, Saxe SR, Bowles RD. The effect of cigarette smoking on anaerobiosis in the oral cavity. J Periodontol 1975;46:82-85.
66. Bardell D, Smith JE. An in vitro study of the exposure of mixed populations of normal oropharyngeal bacteria to cigarette smoke. Microbios 1979;26:159-164.
67. Bradshaw DJ, Marsh PD, Watson GK, Allison C. Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration. Infect Immun 1998;66: 4729-4732.
68. Gell PGH, Coombs RRA. Basic immunological methods. In: Gell PGH, Coombs RRA, Lachmann PJ, eds. Clinical Aspects of Immunology, 3rd ed. London: Blackwell Scientific Publications; 1975:3-53.
69. Lipscomb MF, Huffnagle GB, Lovchik JA, Lyons CR, Pollard AM, Yates JL. The role of T lymphocytes in pulmonary microbial defense mechanisms. Arch Path Lab Med 1993;117:1225-1232.
70. Lipscomb MF, Bice DE, Lyons CR, Schuyler MR, Wilkes D. The regulation of pulmonary immunity. Adv Immunol 1995;59:369-455.
71. Yu H, Hanes M, Chrisp CE, Boucher JC, Deretic V. Microbial pathogenesis in cystic fibrosis: Pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. Infect Immun 1998;66:280-288.
72. Dean EA, Whipp SC, Moon HW. Age-specific colonization of porcine intestinal epithelium by 987P-piliated enterotoxigenic Escherichia coli. Infect Immun 1989;57: 82-87.
73. Apperloo-Renkema HZ, van der Waaij D. Study of colonization resistance for Enterobacteriaceae in man by experimental contamination and biotyping as well as the possible role of antibodies in the clearance of these bacteria from the intestines. Epidemiol Infect 1991;107:619-626.
74. Conlan JW, Perry MB. Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7. Can J Microbiol 1998;44:800-805.
75. Attström R. Presence of leukocytes in crevices of healthy and chronically inflamed gingivae. J Periodont Res 1970;5:42-47.
76. Attström R, Egelberg J. Emigration of blood neutrophils and monocytes into the gingival crevices. J Periodont Res 1970;5:48-55.
77. Attström R, Laurel AB, Lahsson CJ, Sjoholm A. Complement factors in gingival crevice material from healthy and inflamed gingiva in humans. J Periodont Res 1975;10:19-27.
78. Newman HM. Neutrophils and IgG at the host-plaque interface on children's teeth. J Periodontol 1980;51:642-651.
79. Saito I, Komiyama K, Moro I, et al. Ultrastructural and immunocytochemical characterization of polymorphonuclear leukocytes from gingival crevice in man. J Periodontol 1987;58:493-497.
80. Murray PA, Burstein DA, Winkler JR. Antibodies to Bacteroides gingivalis in patients with treated and untreated periodontal disease. J Periodontol 1989;60:96-103.
81. Kenney EB, Kraal JH, Saxe SR, Jones J. The effect of cigarette smoke on human oral polymorphonuclear leukocytes. J Periodont Res 1977;12:227-234.
82. Numabe Y, Ogawa T, Kamoi H, et al. Phagocytic function of salivary PMN after smoking or secondary smoking. Ann Periodontol 1998;3:102-107.
83. Cerami C, Founds H, Nicholl I, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci (USA) 1997;94:13915-13920.
84. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 1998;4:594-601.
85. Nicholl ID, Bucala R. Advanced glycation endproducts and cigarette smoking. Cell Mol Biol 1998;44:1025-1033.
86. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: A two-way relationship. Ann Periodontol 1998;3:51-61.
87. Lalla E, Lamster IB, Feit M, Huang L, Schmidt AM. A murine model of accelerated periodontal disease in diabetes. J Periodont Res 1998;33:387-399.
88. Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 1997;20:1880-1886.
89. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998;37:586-600.
90. Wautier JL, Guillausseau PJ. Diabetes, advanced glycation endproducts and vascular disease. Vasc Med 1998;3:131-137.
91. Li YM, Tan AX, Vlassara H. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nature Med 1995;1:1057-1061.
92. Li YM. Glycation ligand binding motif in lactoferrin. Implications in diabetic infection. Adv Exp Med Biol 1998;443:57-63.
93. Sannomiya P, Oliveira MA, Fortes ZB. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: A direct vital microscopic study. Br J Pharmacol 1997;122:894-898.